You are currently on the new version of our website. Access the old version .

261 Results Found

  • Article
  • Open Access

A Cell-Based Potency Assay for Determining the Relative Potency of Botulinum Neurotoxin A Preparations Using Manual and Semi-Automated Procedures

  • F. Mark Dunning,
  • Sara Hendrickson,
  • Serena Wolfe,
  • Dan Harding,
  • Theresa Geurs,
  • Timothy M. Piazza,
  • Thomas A. Little and
  • Ward C. Tucker
Toxins2026, 18(1), 45;https://doi.org/10.3390/toxins18010045 
(registering DOI)

15 January 2026

Cell-based potency assays (CBPAs) are required for the potency testing and commercial release of botulinum neurotoxin (BoNT)-based drug products. These CBPAs must account for the toxin’s biological activities while meeting regulatory guidelines...

  • Article
  • Open Access
2,449 Views
12 Pages

Development of a Cell-Based Reporter Potency Assay for Live Virus Vaccines

  • Dengyun Sun,
  • Brian K. Meyer,
  • Dhanvanthri S. Deevi,
  • Asra Mirza,
  • Li He,
  • Ashley Gruber,
  • Susan J. Abbondanzo,
  • Noah A. Benton,
  • Melissa C. Whiteman and
  • Robert C. Capen
  • + 1 author

13 July 2024

The rapid development of potency assays is critical in the development of life-saving vaccines. The traditional plaque assay or fifty percent tissue culture infectious dose (TCID50) assay used to measure the potency of live virus vaccines is time con...

  • Article
  • Open Access
298 Views
11 Pages

29 December 2025

(1) Background: As an innovative drug derived from botulinum neurotoxin serotype E, TrenibotulinumtoxinE® demonstrates a rapid onset and shorter effect. Due to concerns regarding specificity, test throughput, and animal welfare, a new cell-based...

  • Article
  • Open Access
11 Citations
7,835 Views
15 Pages

OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays

  • David Rupp,
  • Greg Nicholson,
  • David Canty,
  • Joanne Wang,
  • Catherine Rhéaume,
  • Linh Le,
  • Lance E. Steward,
  • Mark Washburn,
  • Birgitte P. Jacky and
  • Ron S. Broide
  • + 3 authors

13 June 2020

Differences in botulinum neurotoxin manufacturing, formulation, and potency evaluation can impact dose and biological activity, which ultimately affect duration of action. The potency of different labeled vials of incobotulinumtoxinA (Xeomin®; 50...

  • Article
  • Open Access
4 Citations
5,151 Views
18 Pages

19 June 2024

(1) Background: At present, the only potency assay approved in China for the in-country testing of botulinum toxin type A for injection products is the mouse bioassay (MBA). The Chinese market for neurotoxin products is rapidly expanding, but MBAs ar...

  • Article
  • Open Access
6 Citations
5,792 Views
15 Pages

Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations

  • Elena Fonfria,
  • Elizabeth Marks,
  • Lisa-Marie Foulkes,
  • Rebecca Schofield,
  • Daniel Higazi,
  • Sam Coward and
  • Alistair Kippen

29 April 2023

Botulinum neurotoxins (BoNTs) are important therapeutic agents. The in vivo median lethal dose (LD50) assay has been commonly used to measure the potency of BoNT commercial preparations. As an alternative, we developed cell-based assays for abobotuli...

  • Article
  • Open Access
23 Citations
13,377 Views
16 Pages

Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines

  • Nisarg Patel,
  • Zach Davis,
  • Carl Hofmann,
  • Josef Vlasak,
  • John W. Loughney,
  • Pete DePhillips and
  • Malini Mukherjee

10 July 2023

Messenger RNA (mRNA) vaccines have emerged as a flexible platform for vaccine development. The evolution of lipid nanoparticles as effective delivery vehicles for modified mRNA encoding vaccine antigens was demonstrated by the response to the COVID-1...

  • Article
  • Open Access
1 Citations
2,321 Views
13 Pages

28 August 2023

Anthrax toxin is a critical virulence factor of Bacillus anthracis. The toxin comprises protective antigen (PA) and two enzymatic moieties, edema factor (EF) and lethal factor (LF), forming bipartite lethal toxin (LT) and edema toxin (ET). PA binds c...

  • Article
  • Open Access
4 Citations
4,872 Views
16 Pages

CRISPR-Cas9 KO Cell Line Generation and Development of a Cell-Based Potency Assay for rAAV-FKRP Gene Therapy

  • Marine Geoffroy,
  • Louna Pili,
  • Valentina Buffa,
  • Maëlle Caroff,
  • Anne Bigot,
  • Evelyne Gicquel,
  • Grégory Rouby,
  • Isabelle Richard and
  • Romain Fragnoud

12 October 2023

Limb-Girdle Muscular Dystrophy R9 (LGMDR9) is a dystroglycanopathy caused by Fukutin-related protein (FKRP) defects leading to the deficiency of α-DG glycosylation, essential to membrane integrity. Recombinant adeno-associated viral vector (rAA...

  • Article
  • Open Access
25 Citations
5,905 Views
20 Pages

25 April 2020

Botulinum neurotoxins (BoNTs) are potent neurotoxins produced by bacteria, which inhibit neurotransmitter release, specifically in their physiological target known as motor neurons (MNs). For the potency assessment of BoNTs produced for treatment in...

  • Article
  • Open Access
12 Citations
4,493 Views
10 Pages

Cell-Based Reporter Release Assay to Determine the Potency of Proteolytic Bacterial Neurotoxins

  • Andrea Pathe-Neuschäfer-Rube,
  • Frank Neuschäfer-Rube,
  • Gerald Haas,
  • Nina Langoth-Fehringer and
  • Gerhard Paul Püschel

5 September 2018

Despite the implementation of cell-based replacement methods, the mouse lethality assay is still frequently used to determine the activity of botulinum toxin (BoNT) for medical use. One explanation is that due to the use of neoepitope-specific antibo...

  • Article
  • Open Access
5 Citations
5,164 Views
14 Pages

Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists

  • Alessandro Boianelli,
  • Pär Nordell,
  • Joseph Earl,
  • Jacqueline Naylor,
  • David Hornigold,
  • Rasmus Jansson Löfmark and
  • Monika Sundqvist

Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) play an important role in the treatment of type 2 diabetes (T2D) and obesity. The relationship between efficacy and dosing regimen has been studied extensively for this class of molecul...

  • Review
  • Open Access
4 Citations
4,414 Views
12 Pages

Adult stem cells maintaining tissue homeostasis and regeneration are tightly regulated by their specific microenvironments or stem cell niches. The dysfunction of niche components may alter the activity of stem cells and ultimately lead to intractabl...

  • Correction
  • Open Access
1,130 Views
2 Pages

Correction: Patel et al. Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines. Vaccines 2023, 11, 1224

  • Nisarg Patel,
  • Zach Davis,
  • Carl Hofmann,
  • Josef Vlasak,
  • John W. Loughney,
  • Pete DePhillips and
  • Malini Mukherjee

14 February 2025

The authors would like to make the following corrections to this published paper [...]

  • Article
  • Open Access
11 Citations
3,420 Views
12 Pages

20 August 2022

Idiopathic male infertility is a highly prevalent diagnosis in developed countries with no specific treatment options. Although empirical medical treatment is widely used to restore male fertility, its efficacy remains limited and inconclusively prov...

  • Article
  • Open Access
1 Citations
1,811 Views
10 Pages

Cell-Based Relative Potency of a Respiratory Syncytial Virus mRNA Vaccine Correlates with In Vivo Immunogenicity

  • Katrina Feller,
  • Hesham Nawar,
  • Liping Song,
  • Amanda Abrams,
  • Liang Shang,
  • Ashley Gruber,
  • Tatyana Yun and
  • Hualin Helen Li

19 March 2025

Background/Objectives: Potency is a critical quality attribute for vaccine development as well as clinical drug product (DP) lot release and stability testing. Animal studies have the potential to offer conclusive insights about the potency of vaccin...

  • Review
  • Open Access
26 Citations
7,909 Views
23 Pages

7 December 2019

Botulinum Neurotoxins (BoNTs) are a large protein family that includes the most potent neurotoxins known to humankind. BoNTs delivered locally in humans at low doses are widely used pharmaceuticals. Reliable and quantitative detection of BoNTs is of...

  • Article
  • Open Access
3,073 Views
16 Pages

A Quantitative Approach to Potency Testing for Chimeric Antigen Receptor-Encoding Lentiviral Vectors and Autologous CAR-T Cell Products, Using Flow Cytometry

  • Juan José Mata-Molanes,
  • Leticia Alserawan,
  • Carolina España,
  • Carla Guijarro,
  • Ana López-Pecino,
  • Hugo Calderón,
  • Ane Altuna,
  • Lorena Pérez-Amill,
  • Nela Klein-González and
  • Carlos Fernández de Larrea
  • + 4 authors

Background/Objectives: Potency testing of clinical-grade lentiviral vectors (LVVs) is critical to support a drug’s commercial approval. Careful consideration should be paid to the development of a suitable potency test during the drug’s c...

  • Article
  • Open Access
1 Citations
1,998 Views
12 Pages

Interchangeability of the Assays Used to Assess the Activity of Anti-SARS-CoV-2 Monoclonal Antibodies

  • Brady T. Hickerson,
  • Alexey M. Khalenkov,
  • Tao Xie,
  • David M. Frucht,
  • Dorothy E. Scott and
  • Natalia A. Ilyushina

5 August 2023

The recent global COVID-19 pandemic caused by SARS-CoV-2 lasted for over three years. A key measure in combatting this pandemic involved the measurement of the monoclonal antibody (mAb)-mediated inhibition of binding between the spike receptor-bindin...

  • Communication
  • Open Access
77 Citations
9,305 Views
11 Pages

An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles

  • Karin Pachler,
  • Nina Ketterl,
  • Alexandre Desgeorges,
  • Zsuzsanna A. Dunai,
  • Sandra Laner-Plamberger,
  • Doris Streif,
  • Dirk Strunk,
  • Eva Rohde and
  • Mario Gimona

The regenerative and immunomodulatory activity of mesenchymal stromal cells (MSCs) is partially mediated by secreted vesicular factors. Extracellular vesicles (EVs) exocytosed by MSCs are gaining increased attention as prospective non-cellular therap...

  • Article
  • Open Access
1 Citations
2,209 Views
11 Pages

The CombE-IDMS Alternate Potency Method for H5N1 and H5N8 Cell-Based Vaccines

  • Matthew P. Donohue,
  • Zhijun Cao,
  • Thomas Bowen,
  • Robert Dickinson,
  • Ying Zhang and
  • Jiang Qian

1 December 2023

Assaying the potency of inactivated viral influenza vaccines is performed using single radial immunodiffusion, which is the globally accepted release method for potency. Under conditions of a rapidly emerging pandemic, such as the 2009 H1N1 influenza...

  • Review
  • Open Access
16 Citations
9,545 Views
16 Pages

Recent Developments in Botulinum Neurotoxins Detection

  • Christine Rasetti-Escargueil and
  • Michel R. Popoff

Botulinum neurotoxins (BoNTs) are produced as protein complexes by bacteria of the genus Clostridium that are Gram-positive, anaerobic and spore forming (Clostridium botulinum, C. butyricum, C. baratii and C. argentinense spp.). BoNTs show a high imm...

  • Article
  • Open Access
17 Citations
7,584 Views
19 Pages

Synthesis and Biological Evaluation of 3-Benzisoxazolyl-4-indolylmaleimides as Potent, Selective Inhibitors of Glycogen Synthase Kinase-3β

  • Qing Ye,
  • Meng Li,
  • Yubo Zhou,
  • Tao Pang,
  • Lei Xu,
  • Jiayi Cao,
  • Liang Han,
  • Yujin Li,
  • Weisi Wang and
  • Jianrong Gao
  • + 1 author

13 May 2013

A series of novel 3-benzisoxazolyl-4-indolyl-maleimides were synthesized and evaluated for their GSK-3β inhibitory activity. Most compounds exhibited high inhibitory potency towards GSK-3β. Among them, compound 7j with an IC50 value of 0.73 nM was th...

  • Article
  • Open Access
6 Citations
2,838 Views
20 Pages

20 September 2022

Although humans are continuously exposed to complex chemical mixtures in the environment, it has been extremely challenging to investigate the resulting cumulative risks and impacts. Recent studies proposed the use of “new approach methods,&rdq...

  • Article
  • Open Access
2 Citations
2,398 Views
17 Pages

Background/Objectives: Trastuzumab is an effective therapeutic intervention for treating HER2-positive breast cancers. The cost-effectiveness, global demand, and patent expiration of trastuzumab have led to the inflow of its biosimilars in the global...

  • Article
  • Open Access
10 Citations
3,270 Views
11 Pages

Characterization of the Aquaporin-9 Inhibitor RG100204 In Vitro and in db/db Mice

  • Marilina Florio,
  • Angelica Engfors,
  • Patrizia Gena,
  • Jessica Larsson,
  • Alessandro Massaro,
  • Stella Timpka,
  • Martina Kvist Reimer,
  • Per Kjellbom,
  • Eric Beitz and
  • Urban Johanson
  • + 2 authors

4 October 2022

Aquaporin-9 (AQP9) is a facilitator of glycerol and other small neutral solute transmembrane diffusion. Identification of specific inhibitors for aquaporin family proteins has been difficult, due to high sequence similarity between the 13 human isofo...

  • Article
  • Open Access
141 Citations
11,240 Views
16 Pages

Conditioned Medium from Human Mesenchymal Stromal Cells: Towards the Clinical Translation

  • Georgy Sagaradze,
  • Olga Grigorieva,
  • Peter Nimiritsky,
  • Nataliya Basalova,
  • Natalia Kalinina,
  • Zhanna Akopyan and
  • Anastasia Efimenko

Mesenchymal stem/stromal cells (MSC) remain a promising tool for regenerative medicine as the efficacy of MSC-based cell therapy has been demonstrated for a broad spectrum of indications. Their therapeutic potency is mainly associated with their abil...

  • Article
  • Open Access
1,527 Views
23 Pages

25 April 2025

Glucagon-like peptide-2 (GLP-2) is a gut hormone that plays a pivotal role in regulating intestinal epithelial cell growth and function, making it a promising therapeutic agent for intestinal damage and bone-related diseases. Nonetheless, the therape...

  • Review
  • Open Access
51 Citations
16,113 Views
18 Pages

Biotoxin Detection Using Cell-Based Sensors

  • Pratik Banerjee,
  • Spyridon Kintzios and
  • Balabhaskar Prabhakarpandian

29 November 2013

Cell-based biosensors (CBBs) utilize the principles of cell-based assays (CBAs) by employing living cells for detection of different analytes from environment, food, clinical, or other sources. For toxin detection, CBBs are emerging as unique alterna...

  • Article
  • Open Access
23 Citations
6,494 Views
22 Pages

Structure–Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH)

  • Quentin Spillier,
  • Séverine Ravez,
  • Judith Unterlass,
  • Cyril Corbet,
  • Charline Degavre,
  • Olivier Feron and
  • Raphaël Frédérick

22 January 2020

For many years now, targeting deregulation within cancer cells’ metabolism has appeared as a promising strategy for the development of more specific and efficient cancer treatments. Recently, numerous reports highlighted the crucial role of the...

  • Article
  • Open Access
9 Citations
5,358 Views
13 Pages

Antiviral Screen against Canine Distemper Virus-Induced Membrane Fusion Activity

  • Neeta Shrestha,
  • Flavio M. Gall,
  • Jonathan Vesin,
  • Marc Chambon,
  • Gerardo Turcatti,
  • Dimitrios Fotiadis,
  • Rainer Riedl and
  • Philippe Plattet

18 January 2021

Canine distemper virus (CDV), a close relative of the human pathogen measles virus (MeV), is an enveloped, negative sense RNA virus that belongs to the genus Morbillivirus and causes severe diseases in dogs and other carnivores. Although the vaccinat...

  • Article
  • Open Access
7 Citations
5,392 Views
16 Pages

Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT/A1 and B1

  • Maren Schenke,
  • Hélène-Christine Prause,
  • Wiebke Bergforth,
  • Adina Przykopanski,
  • Andreas Rummel,
  • Frank Klawonn and
  • Bettina Seeger

22 August 2021

The application of botulinum neurotoxins (BoNTs) for medical treatments necessitates a potency quantification of these lethal bacterial toxins, resulting in the use of a large number of test animals. Available alternative methods are limited in their...

  • Article
  • Open Access
17 Citations
4,618 Views
18 Pages

31 January 2021

Rift valley fever virus (RVFV) is a mosquito-borne virus endemic to sub-Saharan African countries, and the first sporadic outbreaks outside Africa were reported in the Asia-Pacific region. There are no approved therapeutic agents available for RVFV;...

  • Article
  • Open Access
4 Citations
2,656 Views
15 Pages

Self-assembly of ionically charged small molecule drugs with water-soluble biodegradable polyelectrolytes into nano-scale complexes can potentially offer a novel and attractive approach to improving drug solubility and prolonging its half-life. Nanoa...

  • Article
  • Open Access
14 Citations
3,890 Views
15 Pages

Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease

  • Qian Wang,
  • Guofeng Chen,
  • Jian He,
  • Jiameng Li,
  • Muya Xiong,
  • Haixia Su,
  • Minjun Li,
  • Hangchen Hu and
  • Yechun Xu

The papain-like protease (PLpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a critical role in the proteolytic processing of viral polyproteins and the dysregulation of the host immune response, providing a promising therap...

  • Article
  • Open Access
25 Citations
6,388 Views
26 Pages

Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease

  • Rosa Purgatorio,
  • Nicola Gambacorta,
  • Marco Catto,
  • Modesto de Candia,
  • Leonardo Pisani,
  • Alba Espargaró,
  • Raimon Sabaté,
  • Saverio Cellamare,
  • Orazio Nicolotti and
  • Cosimo D. Altomare

7 December 2020

Thirty-six novel indole-containing compounds, mainly 3-(2-phenylhydrazono) isatins and structurally related 1H-indole-3-carbaldehyde derivatives, were synthesized and assayed as inhibitors of beta amyloid (Aβ) aggregation, a hallmark of pathophysiolo...

  • Review
  • Open Access
4,162 Views
20 Pages

Research Progress on the Detection Methods of Botulinum Neurotoxin

  • Shuo Wang,
  • Huajie Zhang,
  • Yanhua Xue,
  • Yingchao Yang and
  • Liyong Yuan

8 September 2025

Botulinum neurotoxins (BoNTs), produced by the anaerobic spore-forming bacterium Clostridium botulinum, are among the most potent known biological toxins. BoNTs cause lethal botulism via contaminated food, wound infections, or infant intestinal colon...

  • Article
  • Open Access
3 Citations
4,181 Views
14 Pages

The emergence of efficient viral vectors derived from adeno-associated viruses (AAV) has led many groups to develop gene therapies for inherited monogenic diseases, such as retinal dystrophies. To evaluate the potency of new gene therapy vectors in a...

  • Article
  • Open Access
7 Citations
4,002 Views
24 Pages

Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo

  • Cristina Maranto,
  • Vindhya Udhane,
  • Jing Jia,
  • Ranjit Verma,
  • Gerhard Müller-Newen,
  • Peter S. LaViolette,
  • Michael Pereckas,
  • Lavannya Sabharwal,
  • Scott Terhune and
  • Nagarajan Pattabiraman
  • + 4 authors

18 November 2020

Stat5 is of significant interest in the search for new therapeutics for prostate cancer (PC) and hematopoietic disorders. We evaluated the transcriptomic specificity of the Stat5a/b inhibitor IST5-002 (IST5) in PC, defined more closely its mechanisms...

  • Article
  • Open Access
10 Citations
9,133 Views
14 Pages

20 July 2017

Botulinum toxins (BoNTs), of which there are seven serotypes, are among the most potent neurotoxins, with serotypes A, B and E causing human botulism. Antitoxins form the first line of treatment for botulism, and functional, highly sensitive in vitro...

  • Feature Paper
  • Article
  • Open Access
2,612 Views
16 Pages

RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity

  • Ulf Ståhl,
  • Emilia Lekholm,
  • Emil Hamnevik,
  • Robert Fredriksson,
  • Sachin M. Shridharani,
  • Keywan Taghetchian,
  • Joel L. Cohen,
  • Mark S. Nestor and
  • Åsa Liljegren Sundberg

9 October 2025

Most botulinum toxin A (BoNT-A) products for esthetic use require reconstitution before administration. Ready-to-use relabotulinumtoxinA is a liquid manufactured using Precipitation-free Extraction and Activity-preserving, Refined Liquid (PEARL&trade...

  • Article
  • Open Access
8 Citations
4,231 Views
23 Pages

Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease

  • Clare Mills,
  • Sandra A. Hemkemeyer,
  • Zerin Alimajstorovic,
  • Chantelle Bowers,
  • Malihe Eskandarpour,
  • John Greenwood,
  • Virginia Calder,
  • A. W. Edith Chan,
  • Paul J. Gane and
  • David L. Selwood
  • + 2 authors

24 May 2022

Inflammation and fibrosis are important components of diseases that contribute to the malfunction of epithelia and endothelia. The Rho guanine nucleotide exchange factor (GEF) GEF-H1/ARHGEF-2 is induced in disease and stimulates inflammatory and fibr...

  • Article
  • Open Access
3 Citations
3,400 Views
19 Pages

Naturally Derived Phenethyl Isothiocyanate Modulates Induction of Oxidative Stress via Its N-Acetylated Cysteine Conjugated form in Malignant Melanoma

  • Sotiris Kyriakou,
  • Nikoletta Demosthenous,
  • Tom Amery,
  • Kyle J. Stewart,
  • Paul G. Winyard,
  • Rodrigo Franco,
  • Aglaia Pappa and
  • Mihalis I. Panayiotidis

Phenethyl isothiocyanate (PEITC) is a secondary metabolic product yielded upon the hydrolysis of gluconasturtiin and it is highly accumulated in the flowers of watercress. The aim of the current study was to assess the role of a naturally derived PEI...

  • Article
  • Open Access
1 Citations
3,967 Views
14 Pages

In order to improve a recently established cell-based assay to assess the potency of botulinum neurotoxin, neuroblastoma-derived SiMa cells and induced pluripotent stem-cells (iPSC) were modified to incorporate the coding sequence of a reporter lucif...

  • Article
  • Open Access
2 Citations
3,781 Views
20 Pages

Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway

  • Tekle Pauzaite,
  • James Tollitt,
  • Betul Sopaci,
  • Louise Caprani,
  • Olivia Iwanowytsch,
  • Urvi Thacker,
  • John G. Hardy,
  • Sarah L. Allinson and
  • Nikki A. Copeland

Precise regulation of DNA replication complex assembly requires cyclin-dependent kinase (CDK) and Dbf4-dependent kinase (DDK) activities to activate the replicative helicase complex and initiate DNA replication. Chemical probes have been essential in...

  • Article
  • Open Access
24 Citations
8,066 Views
22 Pages

Discovery of Metal Ions Chelator Quercetin Derivatives with Potent Anti-HCV Activities

  • Dongwei Zhong,
  • Mingming Liu,
  • Yang Cao,
  • Yelin Zhu,
  • Shihui Bian,
  • Jiayi Zhou,
  • Fengjie Wu,
  • Kum-Chol Ryu,
  • Lu Zhou and
  • Deyong Ye

16 April 2015

Analogues or isosteres of α,γ-diketoacid (DKA) 1a show potent inhibition of hepatitis C virus (HCV) NS5B polymerase through chelation of the two magnesium ions at the active site. The anti-HCV activity of the flavonoid quercetin (2) could partly be a...

  • Article
  • Open Access
20 Citations
3,990 Views
18 Pages

Uptake and Immunomodulatory Properties of Betanin, Vulgaxanthin I and Indicaxanthin towards Caco-2 Intestinal Cells

  • Yunqing Wang,
  • Ganwarige Sumali N. Fernando,
  • Natalia N. Sergeeva,
  • Nikolaos Vagkidis,
  • Victor Chechik,
  • Thuy Do,
  • Lisa J. Marshall and
  • Christine Boesch

22 August 2022

The present study aimed to compare the absorption and transport patterns of three main betalains, betanin, vulgaxanthin I and indicaxanthin, into intestinal epithelial cells and to assess their distinct molecular effects on inflammatory and redox-rel...

  • Article
  • Open Access
9 Citations
4,165 Views
18 Pages

Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents

  • Matea Juric,
  • Varun Rawat,
  • Radhika Amaradhi,
  • Jacek Zielonka and
  • Thota Ganesh

23 August 2023

A family of seven NADPH oxidase enzymes (Nox1-5, Duox1-2) has been implicated in a variety of diseases, including inflammatory lung diseases, neurodegenerative diseases, cardiovascular diseases, and cancer. Here, we report the results of our studies...

  • Article
  • Open Access
19 Citations
6,605 Views
16 Pages

Discovery of Gramine Derivatives That Inhibit the Early Stage of EV71 Replication in Vitro

  • Yanhong Wei,
  • Liqiao Shi,
  • Kaimei Wang,
  • Manli Liu,
  • Qingyu Yang,
  • Ziwen Yang and
  • Shaoyong Ke

27 June 2014

Enterovirus 71 (EV71) is a notable causative agent of hand, foot, and mouth disease in children, which is associated with an increased incidence of severe neurological disease and death, yet there is no specific treatment or vaccine for EV71 infectio...

  • Article
  • Open Access
14 Citations
8,303 Views
14 Pages

2 November 2016

Treating patients suffering from EGFR mutant non-small cell lung cancer (NSCLC) with first-generation EGFR tyrosine kinase inhibitors (EGFR TKI) provides excellent response rates. However, approximately 60% of all patients ultimately develop drug res...

of 6